Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metvix (PhotoCure).

Kerstin Gardlo1, Thomas Ruzicka

  • 1Heinrich-Heine University, Moorenstrasse 5, 40225 Duesseldorf, Germany. kerstin.lang@med.uni-duesseldorf.de

Current Opinion in Investigational Drugs (London, England : 2000)
|December 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of cognitive symptoms in post COVID-19 patients.

European archives of psychiatry and clinical neuroscience·2024
Same author

ISD (International Society of Dermatology) Mentorship - My Experience.

Indian dermatology online journal·2023
Same author

[In memory of Prof. Dr. med. Percy Lehmann].

Dermatologie (Heidelberg, Germany)·2023
Same author

Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris.

Experimental dermatology·2023
Same author

Indirect immunofluorescence for bullous pemphigoid using ex vivo confocal laser scanning microscopy.

The Journal of dermatology·2023
Same author

Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: A phase 2 randomized clinical trial.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2021
Same journal

Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

Current opinion in investigational drugs (London, England : 2000)·2011
Same journal

Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

Current opinion in investigational drugs (London, England : 2000)·2010
See all related articles

Metvix, a photosensitive cream, uses 5-aminolevulinic acid methyl ester for treating high-risk basal cell carcinoma and actinic keratosis. Developed by PhotoCure, it offers a new therapeutic option for these skin conditions.

Area of Science:

  • Dermatology
  • Photodynamic Therapy

Background:

  • High-risk basal cell carcinoma (BCC) and actinic keratosis (AK) are common skin conditions.
  • Current treatments may have limitations or side effects.

Purpose of the Study:

  • To introduce Metvix (5-aminolevulinic acid methyl ester) as a novel topical treatment.
  • To highlight its application in photodynamic therapy for specific skin conditions.

Main Methods:

  • Metvix is a cream formulation containing 5-aminolevulinic acid methyl ester.
  • It is applied topically and activated by specific light wavelengths.

Main Results:

  • Metvix has been developed and launched by PhotoCure.
  • It is indicated for the treatment of high-risk basal cell carcinoma and actinic keratosis.

Related Experiment Videos

Conclusions:

  • Metvix represents a significant advancement in topical dermatological treatments.
  • It offers a targeted photodynamic therapy approach for challenging skin lesions.